Phase II trial of surufatinib plus toripalimab for disease progression after first-line chemotherapy with platinum and fluoropyrimidine in advanced gastric or gastroesophageal junction adenocarcinoma.
机构：[1]Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China[2]The Second Hospital of Anhui Medical University, Anhui, China[3]The First Affiliated Hospital of Xiamen University, Xiamen, China[4]The Affiliated Hospital of Harbin Medical University, Harbin, China[5]Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[6]Melanoma and Sarcoma Medical Oncology Unit, Sun Yat-sen University Cancer Center, Guangzhou, China[7]Department of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China临床科室消化内科河北医科大学第四医院消化内科.东临床科室[8]The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China[9]West China Hospital of Sichuan University, Sichuan, China四川大学华西医院[10]Sun Yat-sen University Cancer Center, Guangzhou, China[11]The Fourth Hospital of Hebei Medical University, Hebei, China河北医科大学第四医院[12]Hutchison MediPharma Limited, Shanghai, China[13]Hutchison MediPharma Ltd, Shanghai, China
Shen Lin,Lu Ming,Chen Zhendong,et al.Phase II trial of surufatinib plus toripalimab for disease progression after first-line chemotherapy with platinum and fluoropyrimidine in advanced gastric or gastroesophageal junction adenocarcinoma.[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e16040.
APA：
Shen, Lin,Lu, Ming,Chen, Zhendong,Ye, Feng,Zhang, Yanqiao...&Su, Weiguo.(2021).Phase II trial of surufatinib plus toripalimab for disease progression after first-line chemotherapy with platinum and fluoropyrimidine in advanced gastric or gastroesophageal junction adenocarcinoma..JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA：
Shen, Lin,et al."Phase II trial of surufatinib plus toripalimab for disease progression after first-line chemotherapy with platinum and fluoropyrimidine in advanced gastric or gastroesophageal junction adenocarcinoma.".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)
医学